Agilon Health (NYSE:AGL) and INVO Fertility (NASDAQ:IVF) Financial Analysis

INVO Fertility (NASDAQ:IVF) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, institutional ownership and dividends.

Valuation and Earnings

This table compares INVO Fertility and Agilon Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84 million	0.28	-$25.13 million	($33.83)	-0.02
Agilon Health	$5.93 billion	0.23	-$391.35 million	($14.27)	-5.78

INVO Fertility has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

INVO Fertility has a beta of 2.39, indicating that its stock price is 139% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.98, indicating that its stock price is 198% more volatile than the S&P 500.

Insider & Institutional Ownership

12.0% of INVO Fertility shares are held by institutional investors. 0.4% of INVO Fertility shares are held by company insiders. Comparatively, 2.5% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares INVO Fertility and Agilon Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-116.29%	-85.54%	-31.05%
Agilon Health	-3.92%	-119.38%	-16.85%

Analyst Ratings

This is a breakdown of recent ratings and price targets for INVO Fertility and Agilon Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	1	2.50
Agilon Health	2	7	6	0	2.27

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 2,566.67%. Agilon Health has a consensus price target of $102.25, indicating a potential upside of 23.88%. Given INVO Fertility’s stronger consensus rating and higher probable upside, equities analysts plainly believe INVO Fertility is more favorable than Agilon Health.

Summary

INVO Fertility beats Agilon Health on 8 of the 15 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.